International Edition
Latest News
Health

New Cellular Atlas Reveals Why Some DCIS Progress to Invasive Breast Cancer

DCIS occurs when abnormal cells develop within milk ducts but have not yet spread into surrounding tissue. While routine mammography has increased detection rates, roughly 10% to 30% of these cases progress to invasive breast cancer if left…

New Cellular Atlas Reveals Why Some DCIS Progress to Invasive Breast Cancer

DCIS occurs when abnormal cells develop within milk ducts but have not yet spread into surrounding tissue.

While routine mammography has increased detection rates, roughly 10% to 30% of these cases progress to invasive breast cancer if left untreated. This diagnostic uncertainty often leads to aggressive treatments for patients whose lesions might never have become life-threatening.

To address this, researchers used single-cell and spatial profiling to examine 159 patient samples, representing a spectrum from normal tissue to invasive disease. The resulting atlas identified nine major cell types and 60 distinct cell states, revealing that the surrounding microenvironment—including immune cells, blood vessels, and supportive tissue—undergoes significant remodeling during the transition to invasive cancer.

Identifying Cancer Stromal Loops

The team discovered previously unknown ring-like structures, termed “cancer stromal loops,” composed of vascular and supportive tissue cells that encircle DCIS lesions. These structures appear to create an immunosuppressive environment that fosters tumor growth. The data shows that this remodeling of fibroblasts and basal cells begins earlier in the disease process than previous models suggested.

“DCIS is considered a snapshot before breast cancer becomes invasive, but not all DCIS cases progress to invasive disease, and the biology surrounding these lesions has been challenging to examine,” said Nicholas Navin, chair of Systems Biology at MD Anderson and co-leader of the study. “This atlas reveals the surrounding cells and structures that may help disease become invasive.”

Researchers Aim to Develop Tools for Better Risk Assessment

The researchers intend to use this atlas to develop diagnostic tools that can distinguish high-risk lesions from those unlikely to progress. By identifying specific cellular signatures, clinicians may eventually be able to reduce unnecessary interventions for low-risk patients while targeting those who require urgent treatment.

The team acknowledged that further research is required to validate whether these cellular features can serve as reliable clinical predictors. Future studies will focus on assessing the predictive power of these biological markers in diverse patient cohorts to refine individual risk assessment strategies.

Overdiagnosis Challenges Current DCIS Diagnostic Methods

The main issue is overdiagnosis. Because many DCIS lesions never progress to invasive disease, current diagnostic methods struggle to identify which patients truly require aggressive treatment and which can safely avoid it.

While past studies focused primarily on genetic mutations within the cancer cells themselves, this research provides a comprehensive map of the surrounding tumor microenvironment.

It highlights how the interaction between abnormal cells and their neighboring environment drives the disease toward an invasive state.

The current findings provide a foundational atlas that requires further validation. The research team is continuing to investigate these cellular features to determine their potential for use in future diagnostic tools and targeted treatment protocols.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”